HALO Annual Long Term Debt
$1.50 B
+$6.48 M+0.43%
31 December 2023
Summary:
As of January 22, 2025, HALO annual long term debt is $1.50 billion, with the most recent change of +$6.48 million (+0.43%) on December 31, 2023. HALO annual long term debt is now at all-time high.HALO Long Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
HALO Quarterly Long Term Debt
$1.50 B
+$1.64 M+0.11%
30 September 2024
Summary:
As of January 22, 2025, HALO quarterly long term debt is $1.50 billion, with the most recent change of +$1.64 million (+0.11%) on September 30, 2024. Over the past year, it has increased by +$6.53 million (+0.44%). HALO quarterly long term debt is now at all-time high.HALO Quarterly Long Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
HALO Long Term Debt Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +0.4% | +0.4% |
| 3 y3 years | - | +0.4% |
| 5 y5 years | +4199.0% | +0.4% |
HALO Long Term Debt High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +90.4% | at high | +91.1% |
| 5 y | 5-year | at high | +291.4% | at high | +292.7% |
| alltime | all time | at high | at high |
Halozyme Therapeutics Long Term Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $1.50 B(+0.1%) |
| June 2024 | - | $1.50 B(+0.1%) |
| Mar 2024 | - | $1.50 B(+0.1%) |
| Dec 2023 | $1.50 B(+0.4%) | $1.50 B(+0.1%) |
| Sept 2023 | - | $1.50 B(+0.1%) |
| June 2023 | - | $1.50 B(+0.1%) |
| Mar 2023 | - | $1.49 B(+0.1%) |
| Dec 2022 | $1.49 B(+89.6%) | $1.49 B(+0.1%) |
| Sept 2022 | - | $1.49 B(+30.0%) |
| June 2022 | - | $1.15 B(+45.6%) |
| Mar 2022 | - | $788.10 M(+0.1%) |
| Dec 2021 | $787.25 M(+105.5%) | $787.25 M(+0.1%) |
| Sept 2021 | - | $786.45 M(+0.1%) |
| June 2021 | - | $785.57 M(+0.1%) |
| Mar 2021 | - | $784.73 M(+99.4%) |
| Sept 2020 | - | $393.63 M(+0.9%) |
| June 2020 | - | $390.08 M(+0.9%) |
| Mar 2020 | - | $386.57 M(+0.9%) |
| Dec 2019 | $383.05 M(+998.4%) | $383.05 M(+4015.2%) |
| Sept 2019 | - | $9.31 M(-33.9%) |
| June 2019 | - | $14.08 M(-24.9%) |
| Mar 2019 | - | $18.74 M(-46.3%) |
| Dec 2018 | $34.87 M | $34.87 M(-39.8%) |
| Sept 2018 | - | $57.94 M(-26.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2018 | - | $79.08 M(-23.0%) |
| Mar 2018 | - | $102.70 M(-17.9%) |
| Dec 2017 | $125.14 M(-37.2%) | $125.14 M(-13.9%) |
| Sept 2017 | - | $145.42 M(-12.1%) |
| June 2017 | - | $165.52 M(-10.3%) |
| Mar 2017 | - | $184.43 M(-7.4%) |
| Dec 2016 | $199.23 M(+612.3%) | $199.23 M(-0.3%) |
| Sept 2016 | - | $199.80 M(-2.5%) |
| June 2016 | - | $204.85 M(+21.5%) |
| Mar 2016 | - | $168.60 M(+502.8%) |
| Dec 2015 | $27.97 M(-43.9%) | $27.97 M(-18.0%) |
| Sept 2015 | - | $34.09 M(-15.0%) |
| June 2015 | - | $40.10 M(-12.8%) |
| Mar 2015 | - | $45.98 M(-7.8%) |
| Dec 2014 | $49.86 M(+0.2%) | $49.86 M(+25.4%) |
| Sept 2014 | - | $39.76 M(-8.8%) |
| June 2014 | - | $43.61 M(-8.0%) |
| Mar 2014 | - | $47.39 M(-4.8%) |
| Dec 2013 | $49.77 M(+60.0%) | $49.77 M(+89.0%) |
| Sept 2013 | - | $26.33 M(-6.5%) |
| June 2013 | - | $28.18 M(-5.4%) |
| Mar 2013 | - | $29.77 M(-4.3%) |
| Dec 2012 | $31.11 M(>+9900.0%) | $31.11 M(>+9900.0%) |
| Dec 2011 | $0.00 | $0.00 |
FAQ
- What is Halozyme Therapeutics annual long term debt?
- What is the all time high annual long term debt for Halozyme Therapeutics?
- What is Halozyme Therapeutics annual long term debt year-on-year change?
- What is Halozyme Therapeutics quarterly long term debt?
- What is the all time high quarterly long term debt for Halozyme Therapeutics?
- What is Halozyme Therapeutics quarterly long term debt year-on-year change?
What is Halozyme Therapeutics annual long term debt?
The current annual long term debt of HALO is $1.50 B
What is the all time high annual long term debt for Halozyme Therapeutics?
Halozyme Therapeutics all-time high annual long term debt is $1.50 B
What is Halozyme Therapeutics annual long term debt year-on-year change?
Over the past year, HALO annual long term debt has changed by +$6.48 M (+0.43%)
What is Halozyme Therapeutics quarterly long term debt?
The current quarterly long term debt of HALO is $1.50 B
What is the all time high quarterly long term debt for Halozyme Therapeutics?
Halozyme Therapeutics all-time high quarterly long term debt is $1.50 B
What is Halozyme Therapeutics quarterly long term debt year-on-year change?
Over the past year, HALO quarterly long term debt has changed by +$6.53 M (+0.44%)